Skip to main content

Gleevec News

FDA Approves Gleevec for Children with Acute Lymphoblastic Leukemia

January 25, 2013 – The U.S. Food and Drug Administration today approved a new use of Gleevec (imatinib) to treat children newly diagnosed with Philadelphia chromosome positive (Ph+) acute...

FDA Approves Gleevec for Expanded Use in Patients with Rare Gastrointestinal Cancer

The U.S. Food and Drug Administration today granted Gleevec (imatinib) regular approval for use in adult patients following surgical removal of CD117-positive gastrointestinal stromal tumors (GIST)....

FDA Medwatch Alert: Gleevec (imatinib mesylate)

[Posted 10/19/2006] Novartis and FDA notified healthcare professionals about revisions to the PRECAUTIONS section of the prescribing information, describing the occasional occurrence of severe...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Chronic Myelogenous Leukemia (CML), Acute Lymphoblastic Leukemia

Gleevec patient information at Drugs.com